Search | TVST | ARVO Journals

Showing 1 – 20 of 24

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Articles September 2020

Cell-Free DNA Tumor Fraction in the Aqueous Humor Is Associated With Therapeutic Response in Retinoblastoma Patients

PDF

Ashley Polski; Liya Xu; Rishvanth K. Prabakar; Jonathan W. Kim; Rachana Shah; Rima Jubran; Peter Kuhn; David Cobrinik; James Hicks; Jesse L. Berry
TAGS: aqueous humor, cell-free dna, neoplasms, retinoblastoma, hypertension
Trans. Vis. Sci. Tech.. 2020; 9(10):30. https://doi.org/10.1167/tvst.9.10.30

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2020

Longitudinal aqueous humor sampling reflects treatment response in retinoblastoma patients

Ashley Polski; Liya Xu; Rishvanth Prabakar; Jonathan W. Kim; peter kuhn; David Cobrinik; Jim Hicks; Jesse L Berry

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1394.

ARVO Annual Meeting Abstract July 2019

Tumor size criteria for Group D and E eyes in the International Classification System for Retinoblastoma: effect on rates of globe salvage and high-risk histopathologic features

Sona Shah; Jonathan W. Kim; Sarah Green; John O'Fee; Benita Tamrazi; Jesse L Berry

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2325.

ARVO Annual Meeting Abstract July 2019

An Intraocular Pressure Predictive of High-Risk Histopathologic Features in Group E Retinoblastoma Eyes

Mary Elizabeth Kim; Sona Shah; Emily Zolfaghari; Rima Jubran; Mark W. Reid; Jonathan W. Kim; Jesse L Berry

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2330.

ARVO Annual Meeting Abstract July 2018

Chromosomal Analysis in the Aqueous Humor of Retinoblastoma eyes is predictive of globe salvage: the Surrogate Tumor Biopsy

Jesse L Berry; Irsan Kooi; Liya Xu; A Linn Murphree; Bao Han Allison Le; Subramanian Krishnan; Kevin Stachelek; Thomas C Lee; Jonathan W Kim; Peter Kuhn; David Cobrinik; James Hicks

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1637.

ARVO Annual Meeting Abstract July 2018

Quality of Life Outcomes Following Eye Physics Brachytherapy Plaques for the Treatment of Choroidal Melanoma

Arezu Haghighi; Bao han Allison Le; Daniel Yadegari; Jonathan W Kim; Jesse L Berry

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3631.

ARVO Annual Meeting Abstract July 2018

Lack of correlation between Age at Diagnosis and RB1 mutations for Unilateral Retinoblastoma in a Predominantly Hispanic Population: The Importance of Genetic Testing

Abdul-Hadi Kaakour; Jesse L Berry; Laura Lewis; Emily June Zolfaghari; Sarah Green; Thomas C Lee; A Linn Murphree; Jonathan W Kim; Rima Jubran

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1638.

ARVO Annual Meeting Abstract July 2018

Posterior Vitreous Detachment Associated with Retinoblastoma and Intravitreal Melphalan Injections for Vitreous Seeding

Ramon Lee; Luv Patel; Jonathan W Kim; Jesse L Berry

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1645.

ARVO Annual Meeting Abstract July 2018

Integrated Treatment During the Intravitreal Melphalan Era: Concurrent Intravitreal Melphalan and Systemic Chemoreduction

Fiona Kim; Jesse L Berry; Sona Shah; Rima Jubran; Jonathan W Kim

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1647.

ARVO Annual Meeting Abstract July 2018

Outcomes of Choroidal Melanomas Treated with Eye Physics: A 25-Year Review

Bao han Allison Le; Jonathan W Kim; Hao Deng; Nadim Rayess; Richard Jennelle; Jesse L Berry

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3625.

ARVO Annual Meeting Abstract June 2017

Vitreous and Subretinal Seeds in Retinoblastoma: Clinicopathologic Correlation

Alec Lee Amram; Grecia Rico; Jonathan W Kim; Dan Gombos; Patricia Chevez-Barrios

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):855.

ARVO Annual Meeting Abstract June 2017

Magnetic resonance imaging features of the optic nerve in enucleated retinoblastoma patients

Ramon Lee; Jesse L Berry; Ingy Madi; Emily Zolfaghari; Jonathan W Kim

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3334.

ARVO Annual Meeting Abstract June 2017

Optic Nerve Obscuration in Retinoblastoma: a Risk Factor for Optic Nerve Invasion?

Emily June Zolfaghari; Jesse L Berry; Alexander Chen; A. Linn Murphree; Rima Jubran; Jonathan W Kim

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3335.

ARVO Annual Meeting Abstract September 2016

Retrograde Differentiation of Retinoblastoma in Infants

Ananth Sastry; Hassan A Aziz; Jesse L Berry; Jonathan W Kim

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3674.

ARVO Annual Meeting Abstract September 2016

Analysis of Nucleic Acid content in the Aqueous Humor of Retinoblastoma Eyes

Jesse L Berry; Jonathan W Kim

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3669.

ARVO Annual Meeting Abstract September 2016

Acute Vaso-occlusion and Chorioretinal Toxicity following Intravitreal Melphalan Injection

Hassan A Aziz; Jesse L Berry; Jonathan W Kim

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3686.

ARVO Annual Meeting Abstract September 2016

Rabbit model of ocular photodynamic therapy using an indirect ophthalmoscope delivery system.

Jonathan W Kim; Patricia Chevez-Barrios

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3668.

ARVO Annual Meeting Abstract June 2015

Persistence of Subretinal Fluid and the Risk of Enucleation in Group D Retinoblastoma Eyes

Grace Shih; Jesse berry; Stavros Moysidis; A. Linn Murphree; Rima Jubran; Jonathan W Kim

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):6057.

ARVO Annual Meeting Abstract April 2014

Long-term outcomes of Group B eyes in retinoblastoma patients treated with chemoreduction and low-dose IMRT radiation therapy as salvage: The Children’s Hospital Los Angeles Experience.

Dagny Zhu; Jesse L Berry; Rima Jubran; Thomas C Lee; A. Linn Murphree; Jonathan W Kim

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3088.

ARVO Annual Meeting Abstract April 2014

Long-Term Outcomes of Group C Eyes in Retinoblastoma Patients Treated With Chemoreduction and Low-Dose IMRT as Salvage

Lilangi Ediriwickrema; Jesse L Berry; Rima Jubran; Thomas C Lee; A. Linn Murphree; Jonathan W Kim

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3089.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Cell-Free DNA Tumor Fraction in the Aqueous Humor Is Associated With Therapeutic Response in Retinoblastoma Patients

Longitudinal aqueous humor sampling reflects treatment response in retinoblastoma patients

Tumor size criteria for Group D and E eyes in the International Classification System for Retinoblastoma: effect on rates of globe salvage and high-risk histopathologic features

An Intraocular Pressure Predictive of High-Risk Histopathologic Features in Group E Retinoblastoma Eyes

Chromosomal Analysis in the Aqueous Humor of Retinoblastoma eyes is predictive of globe salvage: the Surrogate Tumor Biopsy

Quality of Life Outcomes Following Eye Physics Brachytherapy Plaques for the Treatment of Choroidal Melanoma

Lack of correlation between Age at Diagnosis and RB1 mutations for Unilateral Retinoblastoma in a Predominantly Hispanic Population: The Importance of Genetic Testing

Posterior Vitreous Detachment Associated with Retinoblastoma and Intravitreal Melphalan Injections for Vitreous Seeding

Integrated Treatment During the Intravitreal Melphalan Era: Concurrent Intravitreal Melphalan and Systemic Chemoreduction

Outcomes of Choroidal Melanomas Treated with Eye Physics: A 25-Year Review

Vitreous and Subretinal Seeds in Retinoblastoma: Clinicopathologic Correlation

Magnetic resonance imaging features of the optic nerve in enucleated retinoblastoma patients

Optic Nerve Obscuration in Retinoblastoma: a Risk Factor for Optic Nerve Invasion?

Retrograde Differentiation of Retinoblastoma in Infants

Analysis of Nucleic Acid content in the Aqueous Humor of Retinoblastoma Eyes

Acute Vaso-occlusion and Chorioretinal Toxicity following Intravitreal Melphalan Injection

Rabbit model of ocular photodynamic therapy using an indirect ophthalmoscope delivery system.

Persistence of Subretinal Fluid and the Risk of Enucleation in Group D Retinoblastoma Eyes

Long-term outcomes of Group B eyes in retinoblastoma patients treated with chemoreduction and low-dose IMRT radiation therapy as salvage: The Children’s Hospital Los Angeles Experience.

Long-Term Outcomes of Group C Eyes in Retinoblastoma Patients Treated With Chemoreduction and Low-Dose IMRT as Salvage

To View More...

You must be signed into an individual account to use this feature.